Skip to content
PeptideWiki.bio

Longevity

Glutathione

Also called GSH

InjectableEvidence B2x per week
Half-life
0.1hours
Typical vial
200 / 600mg
Research amounts
600–2000mg

per administration

Common schedule
2x per week
Some human use

It has been used in people, but no trial has settled how much or how often.

The human evidence for Glutathione used the intravenous route. The draw worked out here assumes a subcutaneous injection, so the amount is not a direct read-across.

Quick start

Glutathione at a glance — the figures, plus how it's commonly run. Reference only, not medical advice.

Typical dose
600–2000 mg per administration
How often
2x per week
Where
Intravenous (clinical setting)
Time to steady level
~1 hours — about five half-lives
Storage
Dry vial kept cold and dark; a mixed vial in the fridge at 2–8 °C. Details

A research and community reference, not medical advice. Figures are descriptive, vary between sources, and are not a recommendation for use.

Key properties

Molecular reference data.

Formula
C10H17N3O6S
Mol. weight
307.33 Da
CAS
70-18-8
PubChem CID
124886

Work out your draw

These numbers are a starting point — change any of them.

Vial label

Copy this into your label printer.

Published research contexts for Glutathione describe 6002000 mg per administration. Descriptive only, not a recommendation.

Cleared within minutes after an intravenous dose, so the decay chart is mostly illustrative here.

A tripeptide (γ-Glu-Cys-Gly) given intravenously in small human studies, but no trial fixes a dose-ranging schedule; the circulating amounts are not trial-established, so no schedule table is shown.

Modelled level — 2x per week

1× is the peak after a single dose.

Steady-state peak
0.97× single dose

Read off the modelled curve, not an even-interval formula

Time to steady state
1hours

About five half-lives

Administrations
2/ week

Where these numbers come from

  • Intravenous glutathione literatureSmall intravenous human studies report exposure and tolerability without settling a dose-ranging schedule.

Next steps